Signaling and drug sensitivity
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 13 (2) , 175-189
Abstract
Even though alterations in receptor and nonreceptor kinases are involved in the development of human cancer, many cancer cell lines still retain their responsiveness to growth factors. We have investigated the hypothesis that cellular signaling events regulate the sensitivity of cancer cells to chemotherapeutic agents. In 2008 human ovarian carcinoma cells, activation of a number of different transduction pathways resulted in a 2 to 4-fold increase in the sensitivity to cisplatin. These signaling events include pathways activated by the epidermal growth factor (EGF) receptor, tumor necrosis factor α (TNFα) receptor, bombesin receptor, protein kinase A (PKA), and protein kinase C (PKC). Enhanced sensitivity to chemotherapeutic agents is presumed to be mediated by phosphorylation of critical target protein(s). β-tubulin has been identified as one such target for the protein kinase A signaling cascade. For other signal transduction pathways the key substrates that regulate drug sensitivity have not yet been identified. Recent work has shown that DNA damaging agents activate signaling cascades one of which involves the Src, Ras, and Raf proteins as intermediates and results in induction of a number of genes, including c-fos, c-jun, and the growth arrest and DNA damage??inducible (gadd) genes. This signaling cascade has been shown to involve activation of protein kinase C and to have a protective function. With the growing understanding of how signaling events relate to damage response and drug sensitivity, new and potentially useful strategies for modulating drug sensitivity are evolving.Keywords
This publication has 72 references indexed in Scilit:
- Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cellsInternational Journal of Cancer, 1991
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.Journal of Clinical Investigation, 1991
- Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Journal of Clinical Investigation, 1990
- EGF Receptor and erb B-2 Tyrosine Kinase Domains Confer Cell Specificity for Mitogenic SignalingScience, 1990
- Cells secreting tumour necrosis factor show enhanced metastasis in nude miceEuropean Journal of Cancer and Clinical Oncology, 1990
- Enhancement of Sensitivity of Human Squamous Carcinoma Cells to Radiation by Epidermal Growth FactorJNCI: Journal of the National Cancer Institute, 1989
- Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patientInternational Journal of Cancer, 1987
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987
- PROTEIN SERINE/THREONINE KINASESAnnual Review of Biochemistry, 1987
- Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II)Biochemistry, 1983